Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

Author:

Mateos Maria-Victoria,Blacklock Hilary,Schjesvold Fredrik,Oriol Albert,Simpson David,George Anupkumar,Goldschmidt Hartmut,Larocca Alessandra,Chanan-Khan Asher,Sherbenou Daniel,Avivi Irit,Benyamini Noam,Iida Shinsuke,Matsumoto Morio,Suzuki Kenshi,Ribrag Vincent,Usmani Saad Z,Jagannath Sundar,Ocio Enrique M,Rodriguez-Otero Paula,San Miguel Jesus,Kher Uma,Farooqui Mohammed,Liao Jason,Marinello Patricia,Lonial Sagar,Nicol Andrew,Grigoriadis George,Catalano John,LeBlanc Richard,Elemary Mohamed,Bahlis Nizar,Facon Thierry,Karlin Lionel,Ribrag Vincent,Attal Michel,Goldschmidt Hartmut,Engelhardt Monika,Weisel Katja,Mackensen Andreas,Nagler Arnon,Ben Yehuda Dina,Avivi Irit,Benyamini Noam,Magen-Nativ Hila,Palumbo Antonio,Cavo Michele,Tobinai Kensei,Iida Shinsuke,Chou Takaai,Suzuki Kenshi,Kosugi Hiroshi,Taniwaki Masafumi,Sunami Kazutaka,Matsumoto Morio,Ando Kiyoshi,Ganly Peter,Blacklock Hilary,Simpson David,George Anupkumar,Schjesvold Fredrik,Gjertsen Bjorn,Lahuerta Juan,Blade Joan,Oriol Rocafiguera Albert,Mateos Maria,Rodriguez-Otero Paula,Larson Sarah,Atanackovic Djordje,Devarakonda Srinivas,Bitran Jacob,Zonder Jeffrey,Morganstein Neil,Hay Mohammad,Chanan-Khan Asher,Saylors Gene,Kio Ebenezer,Oliff Ira,Kirkel Dean,Shtivelband Mikhail,Yuen Carrie,Yee Andrew,Shah Jatin,Htut Myo,Raza Shahzad,Chhabra Saurabh,Stiff Patrick,Hari Parameswaran,Bank Bruce,Malek Ehsan,Gasparetto Cristina,Faroun Ycaoub,Sherbenou Daniel,Kreisle William,Singhal Seema,Rosenblatt Jacalyn,Usmani Saad,Lee Wes,Safah Hana,Lutzky Jose,Suh Jason,Pan Dorothy,Baron Ari,Manges Robert,Steis Ronald,Oliveira Moacyr,Moreb Jan,Callander Natalie,Anz Bertrand,Raptis Anastasios,Stampleman Laura,Melear Jason,Boyd Thomas,Garbo Lawrence,Klein Leonard,Shao Spencer,Lyons Roger,McIntyre Kristi,Tarantolo Stefano,Yasenchak Christopher,Yimer Habte

Publisher

Elsevier BV

Subject

Hematology

Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3